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Zerumbone- (ZER-) loaded nanostructure lipid carrier (NLC) (ZER-NLC) prepared for its 
antileukemia effect in vitro was evaluated for its toxicological effects by observing changes 
in the liver, kidney, spleen, lung, heart, and brain tissues, serum biochemical parameters, total 
haemogram, and bone marrow stem cells. The acute toxicity study for ZER-NLC was 
conducted by orally treating BALB/c mice with a single dose with either water, olive oil, 
ZER, NLC, or ZER-NLC for 14 days. The animals were observed for clinical and behavioral 
abnormalities, toxicological symptoms, feed consumption, and gross appearance. The liver, 
kidney, heart, lung, spleen, and brain tissues were assessed histologically. Total haemogram 
was counted by hemocytometry and microhematocrit reader. Bone marrow examination in 
terms of cellular morphology was done by Wright staining with bone marrow smear. 
Furthermore, serum biochemical parameters were determined spectrophotometrically. 
Grossly all treated mice, their investigated tissues, serum biochemical parameters, total 
haemogram, and bone marrow were normal. At oral doses of 100 and 200 mg/kg ZER-NLC 
there was no sign of toxicity or mortality in BALB/c mice. This study suggests that the 50% 
lethal dose (LD50) of ZER-NLC is higher than 200 mg/kg, thus, safe by oral administration. 
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